NUTRA PHARMA CORP
AI Executive Summary
AI-powered analysis of 10-Q filing content
NUTRA PHARMA CORP exhibits severe financial distress with total liabilities of $16.7M against total assets of only $859K, creating a massive stockholders' deficit of $15.8M. Current liabilities of $16.6M vastly exceed current assets of $665K, indicating acute liquidity crisis and potential insolvency.
Red Flags Detected (7)
Massive stockholders' deficit of $15.8M indicating technical insolvency
Current ratio of 0.04 (current assets $665K vs current liabilities $16.6M) showing severe liquidity crisis
Total debt-to-assets ratio exceeding 1900% indicating overleveraging
4 more red flags detected
Key Takeaways
Company appears technically insolvent with liabilities nearly 20x greater than assets
Severe working capital deficit of nearly $16M threatens immediate operations
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.